ZR
ZAHID RAFIQ
The University of Texas at El Paso, MD ANDERSON CANCER CENTER, National Institute of Pharmaceutical Education and Research, University of Kashmir
Research areas: Immunology and Microbiology · Immunology · Cancer Immunotherapy and Biomarkers · Immunotherapy and Immune Responses · Phagocytosis and Immune Regulation
0000-0001-7281-0780
Employment
-
The University of Texas at El Paso Postdoctoral Fellow2025 - Present
-
The University of Texas at El Paso POSTDOCTORAL FELLOW2024 - 2025
-
MD ANDERSON CANCER CENTER POSTDOCTORAL FELLOW2022 - 2024
Education
- 2016 - 2022
- 2013 - 2015
-
The University of Kashmir B.S. Pharmacy2009 - 2013
Projects & Funding
Projects & funding information is unavailable.
Publications (31)
- Regulating the Local Coordination of Cd‐Glutamate Through Ligand Chirality for Efficient Alkaline Hydrogen Evolution Save
- Quantum-Augmented Federated AI for Adaptive Pharmacogenomic Precision Oncology: A Perspective Save
- Algorithm guided personalized T cell therapy: machine learning unlocks next generation TCR engineered immunotherapy. Save
- Tumor Treating Fields (TTFields) sensitize anti-PD1-resistant lung tumors to PD1 blockade and remodel myeloid and lymphoid states Save
- HSPiP, QbD, and Zeneth based green analysis and stability study of valsartan in the presence of mutagenic impurities: an in-silico study for predicting drug safety and quality control Save
- Integrating AI, Machine Learning, and Animal Models for Precision Oncology: Bridging Preclinical and Clinical Gaps Save
- Inhibition of NSD1 by 5-O-Sulfamoyl Adenosine improved 5-FU sensitivity by suppressing cancer cell proliferation and xenograft tumor growth Save
- Abstract 4543: Low dose radiation enhanced antitumor immune response by reprogramming T cell and CAR-T cell metabolism in a tumor immune microenvironment Save
- Abstract 5565: C118S-mediated redox modulation of KRASG12D mutation reprograms immunometabolism to suppress obesity-driven pancreatic tumorigenesis Save
- Enhancing immunotherapy efficacy with synergistic low-dose radiation in metastatic melanoma: current insights and prospects. Save
- Multiple reciprocal interactions within B-cell receptor and AKT signaling pathways regulate response to EZH2 inhibition in germinal center-derived diffuse large B-cell lymphoma Save
- Adaptive magnetic hardness in graphene nanostructures: A Monte Carlo investigation of edge topology and coupling effects Save
- Lead-free NaSiI3 halide perovskite: Linking photovoltaic performance and photocatalytic activity through first-principles and SCAPS-1D modeling Save
- Design and Synthesis of Topoisomerases-Histone Deacetylase Dual Targeted Quinoline-Bridged Hydroxamates as Anticancer Agents. Save
- Enhanced tumor control and survival in preclinical models with adoptive cell therapy preceded by low-dose radiotherapy. Save
- Correction: Novel engineered IL-2 Nemvaleukin alfa combined with PD1 checkpoint blockade enhances the systemic anti-tumor responses of radiation therapy. Save
- Novel engineered IL-2 Nemvaleukin alfa combined with PD1 checkpoint blockade enhances the systemic anti-tumor responses of radiation therapy. Save
- HSPiP, Computational, and Thermodynamic Model-Based Optimized Solvents for Subcutaneous Delivery of Tolterodine Tartrate and GastroPlus‑Based In Vivo Prediction in Humans: Part II. Save
- HSPiP, Computational, and Thermodynamic Model-Based Optimized Solvents for Subcutaneous Delivery of Tolterodine Tartrate and GastroPlus-Based In Vivo Prediction in Humans: Part I. Save
- Inhibition of MER proto-oncogene tyrosine kinase by an antisense oligonucleotide enhances treatment efficacy of immunoradiotherapy. Save